GURUFOCUS.COM » STOCK LIST » Basic Materials » Metals & Mining » Crism Therapeutics Corp (LSE:CRTX) » Definitions » Other Income (Expense)

Crism Therapeutics (LSE:CRTX) Other Income (Expense) : £0.21 Mil (TTM As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Crism Therapeutics Other Income (Expense)?

Crism Therapeutics's other income expense for the Crism Therapeutics's pretax income for the six months ended in Jun. 2024 was £0.30 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2024 was £0.21 Mil.

Crism Therapeutics Other Income (Expense) Historical Data

The historical data trend for Crism Therapeutics's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crism Therapeutics Other Income (Expense) Chart

Crism Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.35 0.23 - -0.32 -0.10

Crism Therapeutics Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.31 - -0.09 0.30

Crism Therapeutics Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crism Therapeutics  (LSE:CRTX) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Crism Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Metals & Mining » Crism Therapeutics Corp (LSE:CRTX) » Definitions » Other Income (Expense)
Comparable Companies
LSE:THR LSE:AYM LSE:GROC LSE:SKA LSE:IMC LSE:AFP LSE:TM1 LSE:EST LSE:UMR LSE:BZT ASX:BHP ASX:RIO LSE:RIO LSE:GLEN SAU:1211 MEX:GMEXICOB BSP:VALE3 LSE:AAL ASX:FMG BOM:500188
Traded in Other Exchanges
N/A
Address
Kingston Chambers, P.O. Box 173, Tortola, Road Town, VGB
Website
https://www.crismtherapeutics.com
Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.

Crism Therapeutics Headlines

No Headlines